Article Versions Notes

Ceci FM, Fiore M, Gavaruzzi F, Angeloni A, Lucarelli M, Scagnolari C, Bonci E, Gabanella F, Di Certo MG, Barbato C, et al. Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section. Diagnostics. 2022; 12(1):176. https://doi.org/10.3390/diagnostics12010176

Ceci, Flavio Maria, Marco Fiore, Francesca Gavaruzzi, Antonio Angeloni, Marco Lucarelli, Carolina Scagnolari, Enea Bonci, Francesca Gabanella, Maria Grazia Di Certo, Christian Barbato, and et al. 2022. "Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section" Diagnostics 12, no. 1: 176. https://doi.org/10.3390/diagnostics12010176

Ceci, F. M., Fiore, M., Gavaruzzi, F., Angeloni, A., Lucarelli, M., Scagnolari, C., Bonci, E., Gabanella, F., Di Certo, M. G., Barbato, C., Petrella, C., Greco, A., Vincentiis, M. D., Ralli, M., Passananti, C., Poscia, R., Minni, A., Ceccanti, M., Tarani, L., & Ferraguti, G. (2022). Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section. Diagnostics, 12(1), 176. https://doi.org/10.3390/diagnostics12010176